Stratial content of Ca2+-dependent regulator protein and dopaminergic receptor function.
D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases / Q000378:metabolism; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D002531:Cerebellum / Q000201:enzymology; D003342:Corpus Striatum / Q000201:enzymology*; D003714:Denervation; D004789:Enzyme Activation / Q000187:drug effects; D005625:Frontal Lobe / Q000201:enzymology; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D009410:Nerve Degeneration; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D009434:Neural Pathways / Q000502:physiology; D009714:Nucleus Accumbens / Q000201:enzymology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D009419:Nerve Tissue Proteins; D011954:Receptors, Dopamine; D014446:Tyrosine 3-Monooxygenase; D015087:2',3'-Cyclic-Nucleotide Phosphodiesterases; D006220:Haloperidol; D001058:Apomorphine; D002118:Calcium